Skip to main content
. Author manuscript; available in PMC: 2013 Sep 9.
Published in final edited form as: Aliment Pharmacol Ther. 2008 Dec 1;29(5):589–601. doi: 10.1111/j.1365-2036.2008.03908.x

Figure 3.

Figure 3

SVR was associated with a 32% increase in cholate Cloral (Panel A), a measure of portal blood flow, and a 26% decrease in cholate shunt (Panel B), a measure of portal-systemic shunting. The dotted line represents one patient with increase in cholate shunt despite SVR – this patient also had the lowest cholate Cloral both at baseline and in followup.